Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1458, 2004-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Does the CV risk with Vioxx elevate earlier than reported?
Reactions Weekly, Vol. 1, Iss. 1103, 2006-01 ,pp. :
Access to resources
Recommend
Merck to pay $US58m in Vioxx settlement
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 555, 2008-01 ,pp. :
Merck announces worldwide suspension of Tredaptive
Reactions Weekly, Vol. 1, Iss. 1436, 2013-01 ,pp. :
CV events persist for one year after stopping Vioxx
Reactions Weekly, Vol. 1, Iss. 1225, 2008-01 ,pp. :